MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer
Tarih
2008Yazar
Saip, P.
Eralp, Y.
Guney, N.
Topuz, E.
Derin, D.
Yavuz, Erdem
Igci, A.
Muslumanoglu, M.
Kucucuk, S.
Dincer, M.
Aydiner, A.
Ozluk, Y.
Üst veri
Tüm öğe kaydını gösterÖzet
Background: Triple-negative breast cancer is estimated to account for 15%-20% of all patients with breast cancer and is considered as a prognostically unfavorable subset. The aim of this study is to evaluate the prognostic impact of various molecular factors in patients with triple-negative breast cancer.
Koleksiyonlar
- Makale [92796]